Form 8-K STEMLINE THERAPEUTICS For: Nov 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Stemline Therapeutics (STML) Tops Q3 EPS by 6c
November 6, 2015 8:04 AM ESTStemline Therapeutics (NASDAQ: STML) reported Q3 EPS of ($0.53), $0.06 better than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Stemline Therapeutics (STML) click here.
... More


